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Workersinthecoking, foundry, andaluminumindustrycanbeexposedtohighconcentrationsofpolycyclicaromatic
hydrocarbons (PAHs) andareatincreased riskforlungcancer, asarecigarettesmokers. Inrecentyearsseveralstudies
onworkersinthefoundryandcokingindustrieshavebeenreported. Inthesestudies, whitebloodcell (WBC) DNAwas
used foranalysis ofPAH-DNAadducts. Theoretically, DNAadduct formation is amore relevant biological parameter
forassessingexposureriskthanPAHintheworkatmosphere,ortheamountofametaboliteintheurine,becauseadduct
levels reflect that partofthedosethatescapesdetoxificationandbindstoDNA. WeanalyzedWBCDNAfromcoke-oven
workersandfromworkersinanaluminumproductionplantanddemonstratedthepresenceofPAH-DNAadducts.Forty-
sevenpercentofthecoke-ovenworkershaddetectablelevelsofPAH-DNAadductsintheirWBCcomparedwith27%of
thecontrols(p < (LO),measuredwithELISA. Inbothgroups,smokershadsigificantly higherlevelsofPAH-DNAadducts
than did nonsmokers. In the aluminum workers, no PAH-DNA adducts were detected by ELISA, although the ben-
zo[aJpyreneconcentrations intheworkatmosphere werecomparable tothoseofthecoke-ovenworkers. Themoresen-
sitive32P-postlabeling assayshowed thepresenceofPAH-DNAadductsin91% ofthealuminumworkers. Therewasno
correlationofWBCadductlevelswiththeconcentrationofPAHintheworkatmosphere. Recently weshowedthattotal
PAH-DNA adduct levels in WBC from lung cancer patients were much higher than those generally found in healthy
smokers. These increased adduct levels may indicate a subpopulation ofsmokers with increased risk for lung cancer,
resultingfromagenetic predispositioninthisgroupofpersons.BecauseWBCsarenotthetargetcellsforexposure-related
cancer, the relationship between PAH-DNA adducts inthelungand in WBCs remains to beestablished.
Introduction
A large number ofchemical carcinogens, such as polycyclic
aromatic hydrocarbons (PAHs), reactcovalently with DNAand
may thereby initiatethemultistage process leading tomalignancy
(1). These DNA adducts may serve asquantitative indicators of
biologicallyeffectivedoses ofspecificcarcinogens. Advances in
analytical methodsduringthelastdecademakepossiblethe sen-
sitive measurementofcovalentadductsofcarcinogens withDNA
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inhumans (2). MethodsofPAH-DNAadductanalysis involve
immunochemical assays(3,4), synchronous fluorescence spec-
troscopy (SFS)(5), and postlabeling of adducted deoxyri-
bonucleotides with [32P]phosphate (6,7). The 32P-postlabeling
analysis is the most sensitive method, and the high specific
radioactivityof[32P]ATPusedinthisprocedureallowsdetection
of 1 adduct in 109 bases (7). However, resolutionofindividual
PAH-DNAadductsfromcomplexmixturesbyTLCisoftendif-
ficult, andseveralmethodshavebeendevelopedtoimprovethe
resolution ofthe 32P-labeledadducted nucleotides. HPLC seems
tobethe mostpromisingapproach tooptimize thedetection of
multipleadductsinoneDNAsample(8,9). Inadditiontobetter
separation of adducted nucleotides, the HPLC method also
facilitates theidentificationofindividual DNAadductsby mass
spectrometry.
Immunochemical methods, i.e., immunoassays ofadducted
DNA or nucleotides and immunocytochemistry oftissues and
cells, employ antibodies that are raised against carcinogen-
modified DNA or nucleosides or nucleotides (3,4). Immu-
noassaysareusuallyperformedascompetitiveELISA(enzyme-
linked immunosorbent assay). The 32P-postlabeling technique,
and in certain cases the ELISA, are sufficiently sensitive toKRIEKETAL.
detect DNA adducts at the levels encountered in humans. A
numberofstudies haveappeared in recentyears inwhichthese
methods have been usedtodetermine DNA adducts in humans
occupationally exposedtoPAHs. Someresultsofourownstudies
are briefly summarized here and are compared with data
reported by other investigators.
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po Airnearcokeovens, inironfoundries, andinaluminumpro-
duction plants contains a number ofcarcinogenic PAHs (10).
Epidemiological studies from several countries have shown an
increased riskoflung canceramongworkers intheseindustries
and the risk appears to correlate with exposure to PAH (10).
Several laboratories have used the 32P-postlabeling technique
and/or immunoassays to determine the biologically effective
dose ofPAH in humans occupationally exposed to PAHs.
Coke Ovens
In anextensive occupational study oncoke-ovenworkers, we
havetestedtheapplicabilityoftheimmunologicdetectionofben-
zo[a]pyrene (BaP)-DNAadducts(11). Atypical PAHprofileof
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FIGURE 1. Mean PAH profile obtained by personal samplingof(A) coke-oven
workers and (B) workers in analuminum productionplant. The main com-
ponents found are: FA, fluoranthene; PYR, pyrene; BA, benz[alanthracene;
CHR, chrysene; BFA, benzo[bjk]fluoranthene; BeP, benzo[e]pyrene; BaP,
benzo[aJpyrene; DBA, dibenz[a,hlanthracene; IP, indeno[l,2,3-cdjpyrene;
BPL, benzo[ghilperylene.
- Non-battery
workers
30-
20-
10-
0
Battery
workers
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17
Samples
FIGURE 2. Whitebloodcell DNAadductsofindividual coke-venworkers in-
volved in battery (shaded bars) and nonbattery (black bars)operations.
thepersonalairsamples isillustrated inFigure IA, which shows
thatfluoranthene, benz[a]anthracene, andbenz(bjk)fluoranthene
arethemostabundantPAHs. Although large fluctuations in ab-
soluteconcentration werenotedoverperiodsofseveraldays, the
PAHprofilewasfairly constant, andBaPcanbeanappropriate
indicator forPAH exposure from thecoke ovens. The levels of
DNAadducts inWBCsfromcoke-ovenbattery workers ranged
up to 20.4 adducts/108 nucleotides and were significantly
increasedcomparedwithnonbattery workers(p<0.05) (Fig. 2).
Nosignificantcorrelations werefoundbetween PAH-DNA ad-
ducts in blood and the air concentrations of total PAHs, BaP
separately, orthosePAHsthatareknowntoformdiolepoxides,
butadose-responserelationship was seenbetweenhoursexpos-
ed and the level of PAH-DNA adducts (r=0.47; p=0.005).
SmokinghadasignificanteffectonthePAH-DNAadductlevels;
inallgroupsexamined smokershadconsistently higherlevelsof
PAH-DNA adducts thandid nonsmokers. Ourdata agree fair-
ly well with those from other studies on coke ovens and iron
foundries (Table 1). Thehigheradductlevelsfoundbyotherin-
vestigators may be the result ofdifferent worker exposures to
PAH and differences in PAH profiles in the various factories.
Comparisonofdata fromdifferentlaboratories, however, should
be done withcaution, for reasons discussed below.
Aluminum Production
Relatively few studieshavebeenreported on PAH-DNA ad-
ductlevels inworkers fromaluminumproductionplants (5,18).
An extensive occupational study in an aluminum production
plantisbeingperformedatpresentinourlaboratory. Atypical
PAH profileofthepersonal air samples is shown in Figure IB,
which shows that in this industry pyrene is the most abundant
PAH. TheobserveddifferencebetweenPAHprofilesofthecoke
ovens and aluminum production plant emphasizes the impor-
tance ofobtaining data on the actual PAH levels present in the
surroundingairoftheworkers. Surprisingly, noPAH-DNAad-
ductsintheWBCsoftheseworkerscouldbedetectedby ELISA
with our anti-benzo[a]pyrene diolepoxide (BPDE)-DNA an-
tibody, althoughtheabsoluteconcentration ofBaPdid notdif-
fer much from that at thecoke ovens. Apparently, exposure to
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Table 1. DNAadduct levelsin workers exposed to PAHsdeterminedby ELISA.
Occupation/process
Roofers
Foundry
Controls
Foundry/high
Foundry/medium
Foundry/low
Controls
Firefighter
Controls
Coke oven
Controls,urban
Controls,rural
Foundry
After vacation
Coke oven, CS
Coke oven, NS
Controls, CS
Controls, NS
No. ofsubjects
Assayed Positive
28 7
20 7
9 2
4 4
13 13
18 13
10 2
43 15
38 13
31 31
15 15
13 13
9 9
9 9
16 11
11 6
28 10
16 2
Adducts/10
Mean ± SD Range
1.2-72
1.8-12
22.7, 28.2
24-48
3-60
0.9-25.8
0.9-9.0
56.1 ± 48.6
34.5 ± 13.8
15.3
13.0
2.3
30.8 ± 6.9
3.9 ± 1.6
7.3 ± 5.9
4.9 ± 5.1
3.0 ± 2.5
1.7 ± 0.7
1.5-20.4
1.5-15.9
1.5-12.9
1.5-4.2
Reference
Shamsuddin etal., 1985 (12)
Shamsuddin etal., 1985 (12)
Shamsuddin etal., 1985 (12)
Perera et al., 1988 (13)
Perera et al., 1988 (13)
Perera et al., 1988 (13)
Perera et al., 1988 (13)
Liou et al., 1989 (14)
Liou et al., 1989 (14)
Hemminki etal., 1990(15)
Hemminki et al., 1990 (15)
Hemminki etal., 1990(15)
Hemminki et al., 1990(16)
Hemminki et al., 1990(16
Van Schooten et al., 1990 (11)
Van Schooten etal., 1990(11)
Van Schooten etal., 1990(11)
Van Schooten et al., 1990 (11)
Abbreviations: PAH, polyaromatic hydrocarbon; ELISA, enzyme-linked immunosorbent assay; PBL, peripherl bloodleukocytes; WBC, white blood cells; CS,
current smoker; NS, nonsmoker.
Table2. DNAadduct levels in workers exposed to PAHdetermined by the32P-postlabeling.
No. ofsubjects Adducts/10' nucleotides
Source Occupation/process Assayed Positive Mean ± SD Range Reference
WBC Foundry/high 4 3 0.2-10 Phillips etal., 1988(17)
WBC Foundry/medium 10 8 0.2-3 Phillips etal., 1988(17)
WBC Foundry/low 18 4 0.2-1 Phillips etal., 1988(17)
WBC Controls 9 1 1.9 Phillipsetal., 1988(17)
WBC Cokeovena 63 63 11.6/24.5 Hemminkietal., 1990(15)
WBC Controls/urbanb 19 19 10.2/21.1 Hemminki etal., 1990(15)
WBC Controls/ruralC 15 15 8.4/4.4 Hemminki etal., 1990(15)
PBL Aluminum/I 25 25 1.48 ± 0.96 0.3-4.1 Schoket etal., 1987(18)
PBL Aluminum/II 21 21 3.08 ± 1.69 0.4-7.1 Schoketetal., 1987(18)
PBL Controls 29 29 1.30 ± 0.53 0.2-2.4 Schoket etal., 1987 (18)
WBC Aluminum 15 13 4.6 ± 6.9 0.1-22 Van Schooten etal., unpublished data
WBC After vacation 14 9 2.2 ± 3.0 0.1-10 Wn Schooten etal., unpublished data
WBC -Day 1d 11 10 2.7 ± 4.4 0.1-15 Van Schooten etal., unpublished data
WBC -Day 3e 11 10 9.6 ± 29 0.1-97 Van Schooten et al., unpublished data
WBC -Day 5f 11 8 6.5 ± 11 0.1-30 Van Schooten etal., unpublisheddata
Abbreviations: PAH, polyaromatic hydrocarbon; WBC, white blood cells; PBL, peripheral blood leukocytes.
aSamples fromcoke-oven workers in Silesia, Poland.
bSamples from the local population in Silesia.
CSamples from a rural population inEastern Poland. Adduct levels weredetermined in twodifferent laboratories(15).
dSamples taken during the working period.
fSamples taken at theend ofthe working period.
similar levels of individual PAH in the ambient air does not
necessarily lead to similar DNAadduct levels in WBCs.
The moresensitive32P-postlabeling assayshowedthepresence
of aromatic DNA adducts in aluminum workers, and some
preliminary data are presented in Table 2. The adduct levels
decreasedbyabout onehalfinthe courseofa2-3 week summer
vacationandtended toincreaseduring a5-dayworkingperiod,
indicatingthatthey arejobrelated. Moredataarebeingobtained,
andtheirstatistical evaluationis inprogress. Atpresent we can-
not explain the differences in ELISA results between the coke
ovenandaluminumplantstudies. Avalueof27% positives inthe
coke-oven control group, which was recruited from a steel-
rolling factoryofthe sameplant, isinagreementwiththevalues
foundby otherinvestigators (Table 1), butis insharpcontrast to
theresultofthealuminumproductionplantwherenoPAH-DNA
adducts inWBCs weredetectable withtheELISA. Itispossible
that there was some exposure to PAH in the steel-rolling
factory, butPAH exposure was notmeasured forthis group(11).
Schoket et al. (18) analyzed peripheral blood lymphocytes
(PBLs) from workers at two aluminum production plants in
Hungary. The meanDNAadductlevelobtainedfromworkersof
only oneplant wassignificantlyhigherthanthatofthecontrols.
The authors attributed this difference to differences in the
technologicaldesign anddifferentlevelsofexposure atthe two
plants. Vhlakangas etal. (5)examinedthe DNA samples from
PBLsof30aluminumplantworkers by SFSandfoundonly one
samplethatcontained a peaksimilar toBPDE-DNA. This result
illustrates thatBaP-DNAadductlevels inhumanWBCs are not
sufficiently high to be detected by SFS.
Comparison ofData
Although wehaveusedsimilarassays, and ourdataagreefairly
well with those reported by other investigators, comparison of
Source
PBL
PBL
PBL
WBS
WBC
WBC
WBC
WBC
WBC
WBC
WBC
WBC
WBC
WBC
WBC
WBC
WBC
WBC
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results fromdifferent laboratories shouldbedonewithcaution.
Unfortunately, interlaboratory standardization of the meth-
odology hasnotyetbeenrealized, despitethe factthatboth im-
munoassaysand the 32P-postlabeling analysis havenowbeenus-
ed for a period of 10 years. For example, the quantification of
DNA adducts by ELISA depends on several factors, including
modification level ofstandard DNA, characteristics ofthepar-
ticular antibody used, thetypeofassay, andtheendpointused.
Underestimation ofadducts inDNAfrombiological sampleshas
been observed by us andother investigators using anti BPDE-
DNA antiseraandseriallydilutionsofhighly modifiedBPDE-
DNA as standards (19,20). Appropriate DNA preparations of
low modification level, obtained from experimental animals
treated with a specific PAH, are required as reference material
when human DNA samples are to beanalyzed.
Similaruncertainties areencountered inthequantificationof
adducts by the32P-postlabeling analysis. Thepostlabelingpro-
cedureisbasedontherelativeresistanceofthePAH-modifiednu-
cleotidesto3'-dephosphorylationbynucleaseP1. However, var-
ious carcinogen-DNA adducts differ in their susceptibility to
nuclease P1 (21). The micrococcal nuclease/spleen phos-
phodiesterasedigestionusedintheoriginal32P-postlabelingpro-
ceduredevelopedbyRanderathfailedtoliberatedeoxyadenosine
adductsquantitatively (22). Thus,eitherdegradationmethodcan
potentiallyleadtoanunderestimationoftheextenttowhichspec-
ific DNA bases have been modified. Indeed, recent data from
Shieldsetal. (23)suggestthatprevious32P-postlabeling studies
forPAH-DNAadductsmayhaveunderestimated adductlevels.
It is clearthat in the future more emphasis shouldbeplaced on
standardizationof32P-postlabeling usinginternalstandards, un-
modifiednucleotidesaswellasauthenticPAHadducts, andcom-
bination withmicropreparative techniques (HPLC) (8,9,23).
Relevance of White Blood Cells As
Nontarget Cells
Acorrelation was foundbetween PAH adductlevels inhuman
lung and exposure to cigarette smoke (24,25), indicating that
PAH-DNAadducts canbe used as an indicator for internal ex-
posure and risk assessment in target tissue. In human studies,
however, target tissue samples can rarely be obtained. Blood
samples are easily available, and the importantquestion arises
whether DNA adduct levels in WBCs reflect adduct levels in
targettissues. Ifthepersistenceoftheadducts inthetargettissue
and its surrogate differs toomuch, theexistenceofacorrelation
isunlikely: TheuseofWBCsasanontargettissue sourceofDNA
wasquestionedbyPhillips etal. (26). Wedidnotfindacorrela-
tionbetweenPAH-DNAadduct levelsinhumanlungandWBCs
(27). Nontarget cells shouldbeeasilyavailable andshouldhave
comparable properties with regard tocarcinogenmetabolism,
DNAbindingandrepair, andturnoverasthetargetcells. Auseful
nontarget source of DNA might be bronchoalveloar
macrophages, obtained by bronchial lavage. Izzotti et al. (28)
report that 85% of pulmonary alveolar macrophage samples
from a group ofcurrent smokers showed typical BPDE-DNA
fluorescencepeaks whenexaminedbySFS, whereas noadducts
were detected in samples from nonsmokers or ex-smokers.
Detailedknowledgeontheaboveparameters forbothtargetcell
type and its surrogate might improvetheutility ofthe latter. In
this respect, moredetailed studies on PAH-DNAadductforma-
tionandrepairinthevarious subpopulations ofWBCs mightbe
very helpful. SeparationofWBCsfollowedbya 18-hrin vitroin-
cubation with 10AM BaPshowed thatthe adductlevel in long-
lived monocytes and lymphocytes was at least 10 times higher
than in short-lived granulocytes (29).
Interindividual and Intraindividual
Variation
Inall populations studied, substantial interindividual variation
in PAH-DNA adduct levels has been observed. Although dif-
ferences inexposurelevels play arole, asoutlinedabove, interin-
dividualdifferences inPAHmetabolism arealso involved. The
higher mean PAH-DNA adduct values (37 + 95 adducts/108
nucleotides) wefound inWBCsfromlungcancerpatientscom-
pared with those reported by Phillips et al. (26) for healthy
smokers (5.53 ± 2.13adducts/108 nucleotides) suggestapredic-
tive valueofPAH-DNAdetection inWBCs. Adisadvantage of
theuseofPAH-DNAadductsinWBCsisthesubstantial intrain-
dividualvariability. ThemajorityofWBC (70-80%) are short-
lived (hours to days), and the various cell types differ also in
metabolizingcapacity. Consequently, theircontributiontoDNA
adduct formation will be different and variable. Recently,
Thompsonetal. (30) showedthathuman lymphocytesdiffered
significantly intheirability tometabolizeandbind PAH in com-
plexmixtures, suchasdieselorganics, cokeovenemissions, and
cigarette smoke condensate. Separation ofWBCs by physical
methods ortheuseofimmunocytochemistry may help to over-
come the problem ofintraindividual variation.
Sensitivity, Reproducibility, and
Applicability
Thehighlevelofsensitivityofthe32P-postlabelingassaywith
alowerdetectionlimitof1 adductin 109nucleotidesisessential
tomeasureadductlevelsoccurringinhumanDNAsamples. The
detectionlimitoftheimmunocytochemicaldetection weuseis7
BPDE-DNAadductsin 108nucleotides. Thismethod, withthe
aidofnewquantificationtechniques(laser-scanmicroscopy), has
promiseforthemeasurementofadductsinhumancellsortissues.
Izzottietal. (27)foundPAH-DNAadductlevelsof 1adductin 107
nucleotidesinalveolarmacrophagesofsmokers, levelsthatseem
sufficienttobedetectedinindividualcellsbyimmunocytochem-
icalmethods. In summary, adduct-specific antibodies arequite
useful invarious specificapplications, i.e., immunocytochem-
istryandenzymeimmunoassays. Aspointedoutalready, further
standardizationandvalidationoftechniques isurgentlyneeded to
avoidsystemicerrorsinmeasurementsbeforethesemethodscan
be applied to large-scale epidemiological studies.
This manuscript was presented at the Conference on Biomonitoring and
Susceptibility Markers inHumanCancer: Applications in Molecular Epidem-
iology andRiskAssessmentthatwasheldinKailua-Kona, Hawaii, 26October-I
November 1991.
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